This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
OFFLU is the joint OIE-FAO global network of expertise on animal influenzas. OFFLU aims to reduce the negative impacts of animal influenza viruses by promoting effective collaboration between animal health experts and the human health sector. OFFLU analyzes and shares information and biological material to identify and reduce health threats early, and shares information about animal influenza viruses with the World Health Organization (WHO) to assist with the early preparation of human vaccines. It was established in 2005, initially to support the global effort to control H5N1 highly pathogenic avian influenza.
The technical contribution to OFFLU is provided by an open network of experts in animal influenza from the OIE and FAO Reference Laboratories and Collaborating Centres, and from other institutes with leading expertise in diagnostics, epidemiology, bioinformatics, vaccinology, and animal production. Under the coordination and management of OFFLU, experts work together in discussion groups called OFFLU Technical Activities on pertinent topics and on technical projects to provide concrete outputs on relevant influenza-related issues. To date, these Technical Activities have delivered guidance on diagnostic protocols, antigenic matching of vaccine strains with circulating field viruses, minimum biosafety guidelines for laboratory workers, and strategic guidance on animal influenza surveillance.
The effectiveness and degree of collaboration between OFFLU and the human health sector (WHO) has improved significantly. This was highlighted following the emergence of pandemic H1N1 in April 2009 when OFFLU rapidly mobilised its experts to address the human-animal interface aspects of pandemic H1N1 jointly with colleagues from the public health sector.
OFFLU continues to develop in terms of scope and geographical representation and is looking ahead to developing a sustainable and effective mechanism for monitoring influenza viruses in animals and for communicating significant findings to all partners quickly.
The OFFLU network is managed by a steering committee who provide strategic direction, an Executive Committee who implement the decisions of the steering committee, a secretariat, and a dedicated OFFLU scientist. The network itself is made up of world leading scientists from a range of fields including virology, epidemiology, bioinformatics, vaccinology, and animal production.
In February 2006, OFFLU launched a campaign for openness when Dr. Ilaria Capua of Italy, chair of the network's Scientific Committee, published sequence data on H5N1 strains from Nigeria and Italy and urged 50 colleagues around the world to share their data. In March, the OFFLU Scientific Committee decided "to put new emphasis on the need for further collection, characterisation, and exchange" of avian flu viruses and for expansion of sequence data, the FAO reported. At about the same time, Capua and four OFFLU colleagues wrote a letter to the journal Science promising to make H5N1 samples available for sequencing." [1]
Influenza A virus (IAV) is a pathogen that causes the flu in birds and some mammals, including humans. It is an RNA virus whose subtypes have been isolated from wild birds. Occasionally, it is transmitted from wild to domestic birds, and this may cause severe disease, outbreaks, or human influenza pandemics.
Avian influenza, also known as avian flu, is a bird flu caused by the influenza A virus, which can infect people. It is similar to other types of animal flu in that it is caused by a virus strain that has adapted to a specific host. The type with the greatest risk is highly pathogenic avian influenza (HPAI).
Influenza A virus subtype H5N1 (A/H5N1) is a subtype of the influenza A virus which can cause illness in humans and many other species. A bird-adapted strain of H5N1, called HPAI A(H5N1) for highly pathogenic avian influenza virus of type A of subtype H5N1, is the highly pathogenic causative agent of H5N1 flu, commonly known as avian influenza. It is enzootic in many bird populations, especially in Southeast Asia. One strain of HPAI A(H5N1) is spreading globally after first appearing in Asia. It is epizootic and panzootic, killing tens of millions of birds and spurring the culling of hundreds of millions of others to stem its spread. Many references to "bird flu" and H5N1 in the popular media refer to this strain.
Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.
An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.
Influenza A virus subtype H3N2 (A/H3N2) is a subtype of viruses that causes influenza (flu). H3N2 viruses can infect birds and mammals. In birds, humans, and pigs, the virus has mutated into many strains. In years in which H3N2 is the predominant strain, there are more hospitalizations.
The global spread of H5N1 influenza in birds is considered a significant pandemic threat. While other H5N1 influenza strains are known, they are significantly different on a genetic level from a recent, highly pathogenic, emergent strain of H5N1, which was able to achieve hitherto unprecedented global spread in 2008. The H5N1 strain is a fast-mutating, highly pathogenic avian influenza virus (HPAI) found in multiple bird species. It is both epizootic and panzootic. Unless otherwise indicated, "H5N1" in this timeline refers to the recent highly pathogenic strain of H5N1.
Transmission and infection of H5N1 from infected avian sources to humans has been a concern since the first documented case of human infection in 1997, due to the global spread of H5N1 that constitutes a pandemic threat.
The Influenza Genome Sequencing Project (IGSP), initiated in early 2004, seeks to investigate influenza evolution by providing a public data set of complete influenza genome sequences from collections of isolates representing diverse species distributions.
H5N1 clinical trials are clinical trials concerning H5N1 vaccines, which are intended to provide immunization to influenza A virus subtype H5N1. They are intended to discover pharmacological effects and identify any adverse reactions the vaccines may achieve in humans.
Spanish flu research concerns studies regarding the causes and characteristics of the Spanish flu, a variety of influenza that in 1918 was responsible for the worst influenza pandemic in modern history. Many theories about the origins and progress of the Spanish flu persisted in the literature, but it was not until 2005, when various samples of lung tissue were recovered from American World War I soldiers and from an Inupiat woman buried in permafrost in a mass grave in Brevig Mission, Alaska, that significant genetic research was made possible.
The global spread of H5N1 in birds is considered a significant pandemic threat.
Fujian flu refers to flu caused by either a Fujian human flu strain of the H3N2 subtype of the Influenza A virus or a Fujian bird flu strain of the H5N1 subtype of the Influenza A virus. These strains are named after Fujian, a coastal province in Southeast China.
GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
Human mortality from H5N1 or the human fatality ratio from H5N1 or the case-fatality rate of H5N1 is the ratio of the number of confirmed human deaths resulting from confirmed cases of transmission and infection of H5N1 to the number of those confirmed cases. For example, if there are 100 confirmed cases of humans infected with H5N1 and 50 die, then there is a 50% human fatality ratio. H5N1 flu is a concern due to the global spread of H5N1 that constitutes a pandemic threat. The majority of H5N1 flu cases have been reported in southeast and east Asia. The case-fatality rate is central to pandemic planning. Estimates of case-fatality (CF) rates for past influenza pandemics have ranged from to 2-3% for the 1918 pandemic to about 0.6% for the 1957 pandemic to 0.2% for the 1968 pandemic. As of 2008, the official World Health Organization estimate for the case-fatality rate for the outbreak of H5N1 avian influenza was approximately 60%. Public health officials in Ontario, Canada argue that the true case-fatality rate could be lower, pointing to studies suggesting it could be 14-33%, and warned that it was unlikely to be as low as the 0.1–0.4% rate that was built into many pandemic plans.
Influenza, commonly known as "the flu" or just "flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.
The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media. For other names, see the Nomenclature section below.
Ilaria Capua is an Italian virologist and former politician, best known for her research on influenza viruses, particularly avian influenza, and her efforts promoting open access to genetic information on emerging viruses as part of pre-pandemic preparedness efforts.
Leo Poon Lit-man (潘烈文) is the Head of the Division of Public Health Laboratory Science of the University of Hong Kong. In July 2020, Professor Malik Peiris stepped down from the position of co-director of the joint research pole between Hong Kong University and the Pasteur Institute (HKU-Pasteur), and Professor Leo Poon succeeded to this crucial WHO recognized Centre. He is one of the worlds' leading scientists investigating the emergence of viral diseases transferring from animals to humans, such as new strains of Influenza viruses and coronaviruses. Along with colleagues in his Division, he has made major contributions to the understanding of disease causes, diagnostic testing, and epidemiological control of these pandemic viral diseases.
Type A influenza vaccine is for the prevention of infection of influenza A virus and also the influenza-related complications. Different monovalent type A influenza vaccines have been developed for different subtypes of influenza A virus including H1N1 and H5N1. Both intramuscular injection or intranasal spray are available on market. Unlike the seasonal influenza vaccines which are used annually, they are usually used during the outbreak of certain strand of subtypes of influenza A. Common adverse effects includes injection site reaction and local tenderness. Incidences of headache and myalgia were also reported with H1N1 whereas cases of fever has also been demonstrated with H5N1 vaccines. It is stated that immunosuppressant therapies would reduce the therapeutic effects of vaccines and that people with egg allergy should go for the egg-free preparations.